Antimicrobial Stewardship
Cross-source consensus on Antimicrobial Stewardship from 1 sources and 4 claims.
1 sources · 4 claims
Uses
Benefits
Risks & contraindications
Comparisons
Highlighted claims
- Amoxicillin is central to global antibiotic stewardship policy as an Access antibiotic. — Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: a systematic review and meta-analysis
- The review's findings are consistent with WHO AWaRe guidance that places amoxicillin first and amoxicillin-clavulanate second for CAP. — Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: a systematic review and meta-analysis
- Strengthening evidence for empirical amoxicillin use in CAP could support the UN target for 70% of human antibiotic consumption to come from Access antibiotics by 2030. — Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: a systematic review and meta-analysis
- Broader-spectrum Watch or Reserve antibiotics may apply greater selection pressure for antimicrobial resistance than Access antibiotics. — Effectiveness of amoxicillin and amoxicillin-clavulanate for the treatment of community-acquired pneumonia in adults and children: a systematic review and meta-analysis